Piper Sandler Companies (NYSE:PIPR) Hits New 1-Year High – What’s Next?

Piper Sandler Companies (NYSE:PIPR)’s stock price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $288.47 and last traded at $307.46, with a volume of 53900 shares changing hands. The stock had previously closed at $302.50.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on PIPR shares. StockNews.com downgraded Piper Sandler Companies from a “buy” rating to a “hold” rating in a report on Tuesday, January 7th. The Goldman Sachs Group lowered shares of Piper Sandler Companies from a “buy” rating to a “neutral” rating and set a $317.00 price target for the company. in a research note on Monday, January 6th.

Piper Sandler Companies Stock Up 1.5 %

The company has a fifty day moving average of $298.95 and a 200 day moving average of $312.03. The company has a market cap of $5.49 billion, a P/E ratio of 33.02 and a beta of 1.46.

Piper Sandler Companies (NYSE:PIPR) last released its quarterly earnings results on Friday, October 25th. The financial services provider reported $2.57 EPS for the quarter, beating the consensus estimate of $2.53 by $0.04. Piper Sandler Companies had a net margin of 10.84% and a return on equity of 16.06%. The firm had revenue of $359.57 million during the quarter, compared to analyst estimates of $365.07 million. As a group, research analysts forecast that Piper Sandler Companies will post 11.49 EPS for the current year.

Piper Sandler Companies Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 13th. Stockholders of record on Friday, November 22nd were paid a $0.65 dividend. The ex-dividend date of this dividend was Friday, November 22nd. This represents a $2.60 annualized dividend and a dividend yield of 0.84%. Piper Sandler Companies’s dividend payout ratio (DPR) is 27.78%.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in PIPR. Nisa Investment Advisors LLC increased its stake in Piper Sandler Companies by 2.6% in the 4th quarter. Nisa Investment Advisors LLC now owns 5,861 shares of the financial services provider’s stock worth $1,758,000 after buying an additional 150 shares in the last quarter. Park Avenue Securities LLC grew its position in shares of Piper Sandler Companies by 46.9% during the fourth quarter. Park Avenue Securities LLC now owns 3,103 shares of the financial services provider’s stock worth $931,000 after purchasing an additional 990 shares in the last quarter. West Oak Capital LLC raised its stake in Piper Sandler Companies by 650.0% during the 4th quarter. West Oak Capital LLC now owns 1,500 shares of the financial services provider’s stock valued at $45,000 after purchasing an additional 1,300 shares during the period. Oliver Luxxe Assets LLC grew its holdings in Piper Sandler Companies by 5.7% during the 4th quarter. Oliver Luxxe Assets LLC now owns 11,838 shares of the financial services provider’s stock valued at $3,551,000 after buying an additional 636 shares in the last quarter. Finally, Modus Advisors LLC bought a new stake in shares of Piper Sandler Companies during the fourth quarter valued at approximately $404,000. 72.79% of the stock is owned by hedge funds and other institutional investors.

Piper Sandler Companies Company Profile

Piper Sandler Companies operates as an investment bank and institutional securities firm that serves corporations, private equity groups, public entities, non-profit entities, and institutional investors in the United States and internationally. It offers investment banking services and institutional sales, trading, and research services for various equity and fixed income products; advisory services, such as mergers and acquisitions, equity and debt private placements, and debt and restructuring advisory; raises capital through equity and debt financings; underwrites municipal issuances; and municipal financial advisory and loan placement services, as well as various over-the-counter derivative products.